61395-22-0 Usage
Purpose
Medication used to treat non-small cell lung cancer
Drug Class
Anaplastic lymphoma kinase (ALK) inhibitors
Works by blocking the activity of ALK and other proteins involved in the growth and spread of cancer cells
Effectiveness
Effective in treating ALK-positive advanced or metastatic non-small cell lung cancer
Can be used as a first-line treatment or for patients who have progressed on other ALK inhibitors
Administration
Taken orally in the form of capsules
Side Effects
Generally well-tolerated
Common side effects include fatigue, muscle pain, and constipation
Clinical Benefits
Demonstrated significant clinical benefits in the treatment of ALK-positive non-small cell lung cancer
An important option for patients with this type of cancer
Check Digit Verification of cas no
The CAS Registry Mumber 61395-22-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,3,9 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 61395-22:
(7*6)+(6*1)+(5*3)+(4*9)+(3*5)+(2*2)+(1*2)=120
120 % 10 = 0
So 61395-22-0 is a valid CAS Registry Number.
61395-22-0Relevant academic research and scientific papers
2-Aryl substituted isoxazolo[2,3-a]pyridinyl halides
-
, (2008/06/13)
2-Aryl substituted isoxazolo[2,3-a]pyridinyl halides having the formula I: SPC1 wherein R1, R2 and R3 are each hydrogen, halogen, hydroxy, lower alkyl, lower alkoxy or lower alkanoyl; R4 is hydrogen or lower alk
